miR-15a-5p and miR-16-5p inhibit cell proliferation in MM by targeting VEGF and CABIN1, as well as inhibiting the AKT and NF-κB pathways [23], all of which have been shown to play an important role in the MM molecular background. This evidence concerns the gene CABIN1 and Miyoshi myopathy.